A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in ...

Isabelle Harrison of the New York Liberty spent much of All-Star weekend visiting her brother Daniel in the hospital ...

Participants who are enrolled will be given a dose of ADI-001, followed by a 28-day dose-limiting toxicity window.

A recent dual-cohort study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment ...

Between 30-50% of those diagnosed with SLE develop kidney disease or lupus nephritis. Learn about treatments, guidelines and more from HSS, a top rheumatology hospital.

Many women with lupus can have safe, successful pregnancies if they plan in advance with their healthcare teams. This article discusses the different pregnancy risk factors every woman who has lupus ...

While hydroxychloroquine (HCQ) helps reduce disease flares in lupus, its effect on renal function in patients with lupus ...

In this video exclusive, Leonard H. Calabrese, DO, chief medical editor of Healio Rheumatology, noted the ongoing efforts to define long COVID and recent data suggesting physicians are not treating ...

DOTHAN, Ala. (WTVY) - There is a gap between rural healthcare providers and lupus care. To address the issue, the Wiregrass Area Health Education Center at Troy University partnered with the Alabama ...

Which of the statements about the 2025 guideline summary for the treatment of systemic lupus erythematosus are correct?

As new treatments for systemic lupus erythematosus and lupus nephritis enter the armamentarium, revitalizing the management ...

The Food and Drug Administration (FDA) has approved Benlysta (belimumab), a B-lymphocyte stimulator-specific inhibitor, for subcutaneous (SC) administration using an autoinjector in patients 5 years ...